Filetype Excel XLSX | Posted on 15 Aug 2022 | 3 years ago
Authentication
digital resources
199x Filetype XLSX File size 1.37 MB Source: www.theglobalfund.org
Sheet 1: FOR REFERENCE ONLY
| Capacity Assessment Tool | ||
| March 2020 | ||
| This template is strictly for reference only. | ||
| It is provided as a preview of relevant module/s in the Global Fund Partner Portal. | ||
| Please do not use this template. | ||
| Capacity Assessment Tool | ||||||||||
| Cover Page | ||||||||||
| Country | Grant | Disease / Component | ||||||||
| Multi | ||||||||||
| Implementer Information | ||||||||||
| Existing Global Fund Implementer Organization name | Organization Abbreviation | Entity Type (NGO, gov't, CBO, INGO) | ||||||||
| Assessment Information | ||||||||||
| Date of this assessment | ||||||||||
| FPM | ||||||||||
| PO | ||||||||||
| HPM | ||||||||||
| FO | ||||||||||
| PHME | ||||||||||
| LO | ||||||||||
| 1. Programmatic and M&E | ||||||
| 1.1 Program design and relevance | ||||||
| LFA Rating | ||||||
| --Please Select-- | ||||||
| Ref | Capacity Questions | Guidance to LFA | LFA Answer | LFA Rating | LFA Mitigating Actions | |
| 1.1.01 | Is there a National Strategic Plan (NSP) available for the disease and for the health sector? Is the disease specific National Strategic Plan aligned to the National Health Sector Strategy? i. Does the NSP period coincide with the grant implementation period ii. Indicate whether the key objectives, indicators and targets in the NSP are aligned with the National Health Sector Strategy iii. Does the program have an operational plan, which is costed and prioritized and linked to NSP? |
--Please Select-- | ||||
| 1.1.02 | Has an assessment/review of the current NSP been conducted? If not, is an assessment planned? What are the key findings, recommendations and actions taken? | --Please Select-- | ||||
| 1.1.03 | Is the program design and are the proposed interventions relevant to the country’s epidemiological and social context and do they address NSP priorities? | --Please Select-- | ||||
| 1.1.04 | Is there an economic analysis of the cost of service delivery to ensure the best value for money in achieving impact? | --Please Select-- | ||||
| 1.1.05 | Are key interventions sufficiently focused on the populations most in need of services and do they address human rights or gender related barriers in access to services? Are the scope and scale of interventions sufficient to achieve desired programmatic coverage, outcome and impact? |
--Please Select-- | ||||
| 1.2 Design and operation capacity of M&E systems | ||||||
| LFA Rating | ||||||
| --Please Select-- | ||||||
| Ref | Capacity Questions | Guidance to LFA | LFA Answer | LFA Rating | LFA Mitigating Actions | |
| 1.2.01 | Is the leadership and support provided by the MoH for the M&E agenda effective? | --Please Select-- | ||||
| 1.2.02 | Is the coordination between M&E Unit / department and disease/HSS programs effective? | --Please Select-- | ||||
| 1.2.03 | Are M&E policies and guidance produced and/or disseminated to sub-national and service level providers? | --Please Select-- | ||||
| 1.2.04 | Are there effective coordination forums by stakeholders involved in M&E activities at national level (e.g., technical working group)? Please consider the following in your response: i. Is there any duplication of M&E efforts/ resources across programs and partners? ii. Is Technical Assistance being used effectively and efficiently (i.e. coordinated recommendations)? |
--Please Select-- | ||||
| 1.2.05 | Is there effective coordination of M&E activities at sub-national level (e.g., partners’ investments at sub-national level are coordinated)? | --Please Select-- | ||||
| 1.2.06 | Is there a National M&E plan and associated operational plan linked to the NSP? | --Please Select-- | ||||
| 1.2.07 | Are indicators to track the progress on implementation of the NSP well defined? Please consider the following in your response: i. Use of standard indicators appropriate to track program performance ii. Availability of robust denominators (e.g., population size and disease burden estimates, etc.) iii. Consistent and accurate baseline data is available |
--Please Select-- | ||||
| 1.2.08 | Is there sufficient funding available for, monitoring and evaluation related activities? Please consider the following in your response: i. Is there an M&E investment plan with clear identification of M&E budget needs and gaps ii. Funding available for implementing M&E activities (included in the NSP budget) iii. Regular follow-up of M&E budget execution |
--Please Select-- | ||||
| 1.2.09 | Are there sufficient human resources, tools and equipment dedicated for M&E? Please consider the following in your response: i. Dedicated staff for data collection at health facility ii. Staff at health facility trained in data collection iii. Sufficient staff for M&E at peripheral and central level that are trained with appropriate skills iv. Is the staff training customized and planned according to identified weaknesses in capacities? v. Adequate hardware and software are available for effective and efficient reporting vi. Appropriate data collection tools (registers, tablets, phones, etc.) are available |
--Please Select-- | ||||
| 1.2.10 | Is there effective feedback mechanisms to lower level of National Health Systems on data quality and regular follow up of recommendations? | --Please Select-- | ||||
| 1.2.11 | Does the data collection and reporting for the grant rely on the national M&E system and will it be used for reporting to the Global Fund? If using a PR specific reporting system, please describe how the PR will integrate the data into the national systems. | --Please Select-- | ||||
| 1.2.12 | Describe the data verification mechanism used by the PR to ensure quality of the reported data and the feedback mechanism from the PR to lower levels of the system (feedback to SR and SSR)? | --Please Select-- | ||||
| 1.2.13 | Indicate if the grant-specific M&E plan includes all indicators and measurement guidance related to the modules/ interventions supported by the GF. | --Please Select-- | ||||
| 1.3 Program quality and efficiency | ||||||
| LFA Rating | ||||||
| --Please Select-- | ||||||
| Ref | Capacity Questions | Guidance to LFA | LFA Answer | LFA Rating | LFA Mitigating Actions | |
| 1.3.01 | Are there guidelines and tools to review quality of services provided? How often is the program quality reviewed at national and sub-national level? | --Please Select-- | ||||
| 1.3.02 | Does the program adhere to approved national or WHO guidelines when selecting medicine formulations, diagnostic tools, or other health products for procurement? | --Please Select-- | ||||
| 1.3.03 | Is there regular training for health staff on guidelines/protocols and appropriate use and delivery of health services and health products, non-discrimination, informed consent, medical confidentiality? (also consider community health workers in your response) | --Please Select-- | ||||
| 1.3.04 | Please describe the mechanisms (e.g., a referral system) to link patients with services essential to comprehensive management of the disease, and/or the monitoring systems for integrated services (diagnostic, treatment and monitoring)? | --Please Select-- | ||||
| 1.3.05 | Are up-to-date guidelines and protocols available at the facility level (in the local language where required)? | --Please Select-- | ||||
| 1.3.06 | Are primary health services providers regulated (e.g., private providers)? | --Please Select-- | ||||
| 1.3.07 | Does the program have the strategy/activities to integrate some of the interventions/activities with other programs (e.g., TB and HIV)? At what level have the interventions/activities been integrated? | --Please Select-- | ||||
| 1.3.08 | Is there a defined package of services to be delivered at community level? Is there an agreed upon list of indicators for collecting data for community level service delivery? | --Please Select-- | ||||
| 1.3.09 | Is there a well-defined scope of work for community health workers? Consider the following in your response: i. Is there a harmonized scope of work for community health workers that covers and facilitates working across all priority programs and/or services ii. Is there a different profile, training plan, salary structure and scope of work across different diseases/regions/programs |
--Please Select-- | ||||
| 1.3.10 | Are there any assurance mechanisms in place to review quality of data reported by the community health workers? | --Please Select-- | ||||
| 1.3.11 | Are there processes in place for regular capacity building, supply management, supervision and feedback to and from the point of care to higher levels of service organization? | --Please Select-- | ||||
| 1.3.12 | Is there a national medical lab strategic plan in place? Are laboratory services integrated to support efficient diagnostic activities and treatment monitoring throughout the levels of the Health care system? | --Please Select-- | ||||
| 1.3.13 | Are there National Quality Standards and a licensing system for laboratory services to ensure quality results for diagnosis and treatment? | --Please Select-- | ||||
| 1.3.14 | Is there is system for monitoring laboratory equipment utilization rates and management of the same? | --Please Select-- | ||||
| 1.4 Limited data availability and data quality | ||||||
| LFA Rating | ||||||
| --Please Select-- | ||||||
| Ref | Capacity Questions | Guidance to LFA | LFA Answer | LFA Rating | LFA Mitigating Actions | |
| 1.5 Limited use of data | ||||||
| LFA Rating | ||||||
| --Please Select-- | ||||||
| Ref | Capacity Questions | Guidance to LFA | LFA Answer | LFA Rating | LFA Mitigating Actions | |
| 1.6 Promotion of human rights and gender equality | ||||||
| LFA Rating | ||||||
| --Please Select-- | ||||||
| Ref | Capacity Questions | Guidance to LFA | LFA Answer | LFA Rating | LFA Mitigating Actions | |
| LFA Summary | ||||||
no reviews yet
Please Login to review.
